Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed von McLeod, Howard L.

Volltext

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update von Amstutz, Ursula, Henricks, Linda M., Offer, Steven M., Barbarino, Julia, Schellens, Jan H.M., Swen, Jesse J., Klein, Teri E., McLeod, Howard L., Caudle, Kelly E., Diasio, Robert B., Schwab, Matthias

Volltext

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study von Gillis, Nancy K, PharmD, Ball, Markus, PhD, Zhang, Qing, MD, Ma, Zhenjun, PhD, Zhao, YuLong, PhD, Yoder, Sean J, MS, Balasis, Maria E, BS, Mesa, Tania E, BS, Sallman, David A, MD, Lancet, Jeffrey E, Prof, Komrokji, Rami S, Prof, List, Alan F, Prof, McLeod, Howard L, Prof, Alsina, Melissa, Prof, Baz, Rachid, MD, Shain, Kenneth H, MD, Rollison, Dana E, PhD, Padron, Eric, Dr

Volltext

Platinum neurotoxicity pharmacogenetics von McWhinney, Sarah R, Goldberg, Richard M, McLeod, Howard L

Volltext

CYP2D6 and tamoxifen: DNA matters in breast cancer von McLeod, Howard L, Hoskins, Janelle M, Carey, Lisa A

Volltext

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy von Knepper, Todd C, Montesion, Meagan, Russell, Jeffery S, Sokol, Ethan S, Frampton, Garrett M, Miller, Vincent A, Albacker, Lee A, McLeod, Howard L, Eroglu, Zeynep, Khushalani, Nikhil I, Sondak, Vernon K, Messina, Jane L, Schell, Michael J, DeCaprio, James A, Tsai, Kenneth Y, Brohl, Andrew S

Volltext

PI3K/Akt/mTOR pathway as a target for cancer therapy von Morgensztern, Daniel, McLeod, Howard L

Volltext

Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects von Evans, William E, McLeod, Howard L

Volltext

Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations von Bonifaz-Peña, Vania, Contreras, Alejandra V, Struchiner, Claudio Jose, Roela, Rosimeire A, Furuya-Mazzotti, Tatiane K, Chammas, Roger, Rangel-Escareño, Claudia, Uribe-Figueroa, Laura, Gómez-Vázquez, María José, McLeod, Howard L, Hidalgo-Miranda, Alfredo, Parra, Esteban J, Fernández-López, Juan Carlos, Suarez-Kurtz, Guilherme

Volltext

Genetic and clinical factors relating to warfarin dosing von Jonas, Daniel E, McLeod, Howard L

Volltext

A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101 von MICHAEL BALDWIN, R, OWZAR, Kouros, FRIEDMAN, Paula N, HUDIS, Clifford A, WINER, Eric P, JORGENSON, Eric M, WITTE, John S, SHULMAN, Lawrence N, NAKAMURA, Yusuke, RATAIN, Mark J, KROETZ, Deanna L, ZEMBUTSU, Hitoshi, CHHIBBER, Aparna, KUBO, Michiaki, JIANG, Chen, WATSON, Dorothy, ECLOV, Rachel J, MEFFORD, Joel, MCLEOD, Howard L

Volltext

miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer von Huang, Jin, He, Yijing, Mcleod, Howard L, Xie, Yanchun, Xiao, Desheng, Hu, Huabin, Chen, Pan, Shen, Liangfang, Zeng, Shan, Yin, Xianli, Ge, Jie, Li, Li, Tang, Lanhua, Ma, Jian, Chen, Zihua

Volltext

Pharmacogenetic Assessment of Toxicity and Outcome After Platinum Plus Taxane Chemotherapy in Ovarian Cancer: The Scottish Randomised Trial in Ovarian Cancer von MARSH, Sharon, PAUL, Jim, KING, Cristi R, GIFFORD, Gillian, MCLEOD, Howard L, BROWN, Robert

Volltext

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity von Hertz, Daniel L, McLeod, Howard L

Volltext

High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple antic... von Akhtari, Farida S., Green, Adrian J., Small, George W., Havener, Tammy M., House, John S., Roell, Kyle R., Reif, David M., McLeod, Howard L., Wiltshire, Timothy, Motsinger-Reif, Alison A.

Volltext

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741 von MCLEOD, Howard L, SARGENT, Daniel J, GROTHEY, Axel, MORTON, Roscoe F, GOLDBERG, Richard M, MARSH, Sharon, GREEN, Erin M, KING, Cristi R, FUCHS, Charles S, RAMANATHAN, Ramesh K, WILLIAMSON, Stephen K, FINDLAY, Brian P, THIBODEAU, Stephen N

Volltext

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance) von Quintanilha, Julia C F, Sibley, Alexander B, Liu, Yingmiao, Niedzwiecki, Donna, Halabi, Susan, Rogers, Layne, O'Neil, Bert, Kindler, Hedy, Kelly, William, Venook, Alan, McLeod, Howard L, Ratain, Mark J, Nixon, Andrew B, Innocenti, Federico, Owzar, Kouros

Volltext

Modeling the 5‐Fluorouracil Area Under the Curve Versus Dose Relationship to Develop a Pharmacokinetic Dosing Algorithm for Colorectal Cancer Patients Receiving FOLFOX6 von Kaldate, Rajesh R., Haregewoin, Abebe, Grier, Charles E., Hamilton, Stephanie A., McLeod, Howard L.

Volltext

Using Pharmacogene Polymorphism Panels to Detect Germline Pharmacodynamic Markers in Oncology von HERTZ, Daniel L, McLEOD, Howard L

Volltext

Tamoxifen and CYP2D6: A Contradiction of Data von Hertz, Daniel L., McLeod, Howard L., Irvin, William J.

Volltext